Recruiting
An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol
The primary objective of the investigators is to develop an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. This will be achieved by retrospectively analysing a subgroup of patients who had breast cancer-related surgery prior to lymphedema.
ClinicalTrials.gov IDNCT06374745
PhaseNot Applicable
Enrollment500
SponsorUniversity Hospital, Basel, Switzerland
AgeNo minimum reported
SexALL
Conditions studied
Lymphedema, Breast Cancer
About this study
The primary objective of the investigators is to develop an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. This will be achieved by retrospectively analysing a subgroup of patients who had breast cancer-related surgery prior to lymphedema.
Primary outcomes
- To design an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. (baseline to follow up (no later than December 2024))
- Date of follow-up procedure (baseline to follow up (no later than December 2024))
- Follow-up and type of lymphedema surgery (baseline to follow up (no later than December 2024))
- Circumferences of the affected and unaffected side (baseline to follow up (no later than December 2024))
- Postoperative complications (baseline to follow up (no later than December 2024))
- Surgery duration. (baseline to follow up (no later than December 2024))
- Type of lymphedema surgery (baseline to follow up (no later than December 2024))
- Date of lymphedema surgery (baseline to follow up (no later than December 2024))
Eligibility information
Inclusion Criteria:
* status post breast cancer or status post another type of cancer or status post no cancer
* chronic lymphedema - lymphedema lasting over three months - present prior to surgical treatment
* one type of surgical procedure for treatment of chronic lymphedema or a combination of surgical procedures for treatment of chronic lymphedema was performed
* one or any combination of the following surgical procedures was used in each individual patient: Lymph Node-Vein Anastomosis (LNVA) , Lymphaticovenous Anastomosis (LVA), Tumescent Liposuction (TL), Vascularized Lymph Node Transfer (VLNT) and/or Water-Assisted Liposuction (WAL)
Exclusion Criteria:
* inclusion criteria not met
* loss to follow-up (data not successfully collected)
Study locations
- University Hospital Basel, Basel, 4031 Switzerland
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.